[2021.06] Absolology innovates medical devices with in vitro diagnostic platform 'ABSOL' > news

본문 바로가기
ABSOL VET Contact Us Login
  • · Korean
  • · English

Absology will be with you all the time.
With us, begin a new era of In-vitro Diagnosis.

[2021.06] Absolology innovates medical devices with in vitro diagnosti…



[Summery]  he first target is tau protein, which is known to influence the development of several degenerative brain diseases, including frontal dementia and Alzheimer's disease. PeopleBio and Absolology will first begin developing a blood-based diagnostic kit that measures tau protein, an important factor in Alzheimer's disease. It also plans to jointly develop upgraded products in the beta amyloid field.



Excerpt from Financial News